Patrick Mauro Investment Advisor INC. Has $12.49 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Patrick Mauro Investment Advisor INC. cut its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 4.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 53,760 shares of the financial services provider's stock after selling 2,409 shares during the quarter. CME Group comprises 7.1% of Patrick Mauro Investment Advisor INC.'s investment portfolio, making the stock its largest holding. Patrick Mauro Investment Advisor INC.'s holdings in CME Group were worth $12,485,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Orion Capital Management LLC acquired a new position in shares of CME Group during the fourth quarter valued at $248,000. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its stake in CME Group by 14.8% in the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 68,955 shares of the financial services provider's stock valued at $16,013,000 after purchasing an additional 8,876 shares during the period. Focus Partners Advisor Solutions LLC raised its holdings in shares of CME Group by 61.0% during the 4th quarter. Focus Partners Advisor Solutions LLC now owns 1,671 shares of the financial services provider's stock worth $388,000 after buying an additional 633 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in CME Group by 14.9% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,437,662 shares of the financial services provider's stock worth $566,098,000 after purchasing an additional 315,813 shares in the last quarter. Finally, Waverly Advisors LLC increased its stake in shares of CME Group by 32.2% in the fourth quarter. Waverly Advisors LLC now owns 10,827 shares of the financial services provider's stock valued at $2,514,000 after buying an additional 2,637 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on CME shares. Piper Sandler upped their target price on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research report on Tuesday, April 8th. UBS Group raised their target price on CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research report on Friday, April 25th. Oppenheimer lifted their price objective on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a research note on Friday, April 11th. Morgan Stanley boosted their target price on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research report on Thursday, April 24th. Finally, Raymond James upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective for the company in a research report on Monday, March 10th. Three analysts have rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $256.80.

Insider Activity at CME Group

In other CME Group news, COO Suzanne Sprague sold 1,500 shares of the business's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the sale, the chief operating officer now directly owns 8,036 shares of the company's stock, valued at $2,063,885.88. The trade was a 15.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of the business's stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $273.17, for a total transaction of $81,951.00. Following the transaction, the director now owns 24,767 shares in the company, valued at approximately $6,765,601.39. This represents a 1.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 28,384 shares of company stock valued at $7,531,053 over the last three months. 0.30% of the stock is owned by insiders.

CME Group Stock Performance

CME traded down $0.35 on Tuesday, hitting $283.72. 585,106 shares of the company traded hands, compared to its average volume of 2,185,506. The company has a 50 day moving average of $268.20 and a 200-day moving average of $249.76. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $102.24 billion, a PE ratio of 29.32, a PEG ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $286.48.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the business posted $2.50 EPS. Sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's payout ratio is 50.30%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.